Health benefits of combined oral contraceptives - a narrative review
CONCLUSIONS: The use of combined oral contraceptives is accompanied with a range of health benefits, to be balanced against its side-effects and risks. Several health benefits of COCs are a reason for non-contraceptive COC prescription.PMID:38426312 | DOI:10.1080/13625187.2024.2317295 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Herjan J T Coelingh Bennink Femke A M van Gennip Mireille G F Gerrits Jan F M Egberts Kristina Gemzell-Danielsson Helena Kopp-Kallner Source Type: research

The role of progestin subdermal implant in the management of adenomyosis: a systematic review
CONCLUSION: ENG implant may be a relevant and promising medical option in the management of adenomyosis. Nevertheless, randomised controlled trials and prospective studies with larger cohorts are needed to confirm the potential role of ENG implant in the management of adenomyosis.PMID:38426337 | DOI:10.1080/13625187.2024.2314298 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: G Chene H Baffet E Cerruto E Nohuz A Agostini Source Type: research

Let's reconsider modern progestin-only pills during isotretinoin and retinoid therapy
Eur J Contracept Reprod Health Care. 2024 Mar 1:1-3. doi: 10.1080/13625187.2024.2315239. Online ahead of print.NO ABSTRACTPMID:38426353 | DOI:10.1080/13625187.2024.2315239 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Marco Manfredini Lucio Di Castri Giovanni Grandi Source Type: research

Health benefits of combined oral contraceptives - a narrative review
CONCLUSIONS: The use of combined oral contraceptives is accompanied with a range of health benefits, to be balanced against its side-effects and risks. Several health benefits of COCs are a reason for non-contraceptive COC prescription.PMID:38426312 | DOI:10.1080/13625187.2024.2317295 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Herjan J T Coelingh Bennink Femke A M van Gennip Mireille G F Gerrits Jan F M Egberts Kristina Gemzell-Danielsson Helena Kopp-Kallner Source Type: research

The role of progestin subdermal implant in the management of adenomyosis: a systematic review
CONCLUSION: ENG implant may be a relevant and promising medical option in the management of adenomyosis. Nevertheless, randomised controlled trials and prospective studies with larger cohorts are needed to confirm the potential role of ENG implant in the management of adenomyosis.PMID:38426337 | DOI:10.1080/13625187.2024.2314298 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: G Chene H Baffet E Cerruto E Nohuz A Agostini Source Type: research

Let's reconsider modern progestin-only pills during isotretinoin and retinoid therapy
Eur J Contracept Reprod Health Care. 2024 Mar 1:1-3. doi: 10.1080/13625187.2024.2315239. Online ahead of print.NO ABSTRACTPMID:38426353 | DOI:10.1080/13625187.2024.2315239 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Marco Manfredini Lucio Di Castri Giovanni Grandi Source Type: research

Health benefits of combined oral contraceptives - a narrative review
CONCLUSIONS: The use of combined oral contraceptives is accompanied with a range of health benefits, to be balanced against its side-effects and risks. Several health benefits of COCs are a reason for non-contraceptive COC prescription.PMID:38426312 | DOI:10.1080/13625187.2024.2317295 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Herjan J T Coelingh Bennink Femke A M van Gennip Mireille G F Gerrits Jan F M Egberts Kristina Gemzell-Danielsson Helena Kopp-Kallner Source Type: research

The role of progestin subdermal implant in the management of adenomyosis: a systematic review
CONCLUSION: ENG implant may be a relevant and promising medical option in the management of adenomyosis. Nevertheless, randomised controlled trials and prospective studies with larger cohorts are needed to confirm the potential role of ENG implant in the management of adenomyosis.PMID:38426337 | DOI:10.1080/13625187.2024.2314298 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: G Chene H Baffet E Cerruto E Nohuz A Agostini Source Type: research

Let's reconsider modern progestin-only pills during isotretinoin and retinoid therapy
Eur J Contracept Reprod Health Care. 2024 Mar 1:1-3. doi: 10.1080/13625187.2024.2315239. Online ahead of print.NO ABSTRACTPMID:38426353 | DOI:10.1080/13625187.2024.2315239 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Marco Manfredini Lucio Di Castri Giovanni Grandi Source Type: research

Health benefits of combined oral contraceptives - a narrative review
CONCLUSIONS: The use of combined oral contraceptives is accompanied with a range of health benefits, to be balanced against its side-effects and risks. Several health benefits of COCs are a reason for non-contraceptive COC prescription.PMID:38426312 | DOI:10.1080/13625187.2024.2317295 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Herjan J T Coelingh Bennink Femke A M van Gennip Mireille G F Gerrits Jan F M Egberts Kristina Gemzell-Danielsson Helena Kopp-Kallner Source Type: research

The role of progestin subdermal implant in the management of adenomyosis: a systematic review
CONCLUSION: ENG implant may be a relevant and promising medical option in the management of adenomyosis. Nevertheless, randomised controlled trials and prospective studies with larger cohorts are needed to confirm the potential role of ENG implant in the management of adenomyosis.PMID:38426337 | DOI:10.1080/13625187.2024.2314298 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: G Chene H Baffet E Cerruto E Nohuz A Agostini Source Type: research

Let's reconsider modern progestin-only pills during isotretinoin and retinoid therapy
Eur J Contracept Reprod Health Care. 2024 Mar 1:1-3. doi: 10.1080/13625187.2024.2315239. Online ahead of print.NO ABSTRACTPMID:38426353 | DOI:10.1080/13625187.2024.2315239 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Marco Manfredini Lucio Di Castri Giovanni Grandi Source Type: research

Health benefits of combined oral contraceptives - a narrative review
CONCLUSIONS: The use of combined oral contraceptives is accompanied with a range of health benefits, to be balanced against its side-effects and risks. Several health benefits of COCs are a reason for non-contraceptive COC prescription.PMID:38426312 | DOI:10.1080/13625187.2024.2317295 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Herjan J T Coelingh Bennink Femke A M van Gennip Mireille G F Gerrits Jan F M Egberts Kristina Gemzell-Danielsson Helena Kopp-Kallner Source Type: research

The role of progestin subdermal implant in the management of adenomyosis: a systematic review
CONCLUSION: ENG implant may be a relevant and promising medical option in the management of adenomyosis. Nevertheless, randomised controlled trials and prospective studies with larger cohorts are needed to confirm the potential role of ENG implant in the management of adenomyosis.PMID:38426337 | DOI:10.1080/13625187.2024.2314298 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: G Chene H Baffet E Cerruto E Nohuz A Agostini Source Type: research

Let's reconsider modern progestin-only pills during isotretinoin and retinoid therapy
Eur J Contracept Reprod Health Care. 2024 Mar 1:1-3. doi: 10.1080/13625187.2024.2315239. Online ahead of print.NO ABSTRACTPMID:38426353 | DOI:10.1080/13625187.2024.2315239 (Source: The European Journal of Contraception and Reproductive Health Care)
Source: The European Journal of Contraception and Reproductive Health Care - March 1, 2024 Category: Reproduction Medicine Authors: Marco Manfredini Lucio Di Castri Giovanni Grandi Source Type: research